share_log

EF Hutton Maintains Buy on Hoth Therapeutics, Raises Price Target to $7

Moomoo 24/7 ·  Apr 2 09:03

EF Hutton analyst Tim Moore maintains Hoth Therapeutics (NASDAQ:HOTH) with a Buy and raises the price target from $6.5 to $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment